SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-456770
Filing Date
2012-11-07
Accepted
2012-11-07 13:08:08
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d435748d10q.htm 10-Q 393610
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 d435748dex311.htm EX-31.1 9765
3 CERTIFICATION OF PFO PURSUANT TO SECTION 302 d435748dex312.htm EX-31.2 9783
4 CERTIFICATION OF CEO AND PFO PURSUANT TO SECTION 906 d435748dex321.htm EX-32.1 4766
  Complete submission text file 0001193125-12-456770.txt   2321346

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT agen-20120930.xml EX-101.INS 191283
6 XBRL TAXONOMY EXTENSION SCHEMA agen-20120930.xsd EX-101.SCH 22294
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agen-20120930_cal.xml EX-101.CAL 35280
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agen-20120930_def.xml EX-101.DEF 68013
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20120930_lab.xml EX-101.LAB 229786
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20120930_pre.xml EX-101.PRE 163675
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 121185881
SIC: 2836 Biological Products, (No Diagnostic Substances)